236 related articles for article (PubMed ID: 8137250)
1. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.
Schwartz EL; Baptiste N; O'Connor CJ; Wadler S; Otter BA
Cancer Res; 1994 Mar; 54(6):1472-8. PubMed ID: 8137250
[TBL] [Abstract][Full Text] [Related]
2. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
[TBL] [Abstract][Full Text] [Related]
3. Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo.
Ciccolini J; Cuq P; Evrard A; Giacometti S; Pelegrin A; Aubert C; Cano JP; Iliadis A
Mol Cancer Ther; 2001 Dec; 1(2):133-9. PubMed ID: 12467230
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J
Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells.
Schwartz EL; Hoffman M; O'Connor CJ; Wadler S
Biochem Biophys Res Commun; 1992 Feb; 182(3):1232-9. PubMed ID: 1540167
[TBL] [Abstract][Full Text] [Related]
6. Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil.
Schwartz EL; Baptiste N; Wadler S; Makower D
J Biol Chem; 1995 Aug; 270(32):19073-7. PubMed ID: 7642571
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
8. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human interferon alpha-2a increases 5-fluorouracil efficacy by elevating fluorouridine concentration in tumor tissue.
Kase S; Kubota T; Watanabe M; Teramoto T; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(3A):1155-9. PubMed ID: 8074466
[TBL] [Abstract][Full Text] [Related]
10. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of the intracellular activation of 5-fluorouracil to deoxyribonucleotides in HT29 human colon cell line: application to modulation of metabolism and cytotoxicity study.
Ciccolini J; Peillard L; Aubert C; Formento P; Milano G; Catalin J
Fundam Clin Pharmacol; 2000; 14(2):147-54. PubMed ID: 10796062
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
[TBL] [Abstract][Full Text] [Related]
13. Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
Ismail A; Van Groeningen CJ; Hardcastle A; Ren Q; Aherne GW; Geoffroy F; Allegra CJ; Grem JL
Mol Pharmacol; 1998 Feb; 53(2):252-61. PubMed ID: 9463483
[TBL] [Abstract][Full Text] [Related]
14. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
15. [Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts].
Jin CD; Yamamoto T; Nakamura M; Arai I; Kishin R; Xing X; Nagano H; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1511-5. PubMed ID: 15508442
[TBL] [Abstract][Full Text] [Related]
16. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
[TBL] [Abstract][Full Text] [Related]
18. Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells.
van der Wilt CL; Smid K; Aherne GW; Noordhuis P; Peters GJ
Eur J Cancer; 1997 Mar; 33(3):471-8. PubMed ID: 9155534
[TBL] [Abstract][Full Text] [Related]
19. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
Tillman DM; Petak I; Houghton JA
Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
[TBL] [Abstract][Full Text] [Related]
20. Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo.
Makower D; Wadler S; Haynes H; Schwartz EL
Clin Cancer Res; 1997 Jun; 3(6):923-9. PubMed ID: 9815767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
